Avita Medical Inc (RCEL)

AVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual Meeting

First U.K. case series demonstrates successful use of RECELL GO® in 17 burn and reconstructive surgery...

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., May 17, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

AVITA Medical Reports First Quarter 2026 Financial Results

VALENCIA, Calif., May 14, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

Form 8-K - Current report

AVITA Medical Names Cary Vance as Chief Executive Officer

Board appoints Cary Vance as President and Chief Executive Officer Follows successful interim tenure and...

AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO

RECELL GO® receives regulatory clearance in Australia and New Zealand, enabling commercialization across both...

AVITA Medical to Announce First Quarter 2026 Financial Results

VALENCIA, Calif., April 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...

AVITA Medical Founder Fiona Wood Honored with Lifetime Achievement Award by American Burn Association

Recognition highlights pioneering contributions to modern burn care including development of RECELL® Spray-On...

AVITA Medical Announces Positive Interim Results from Cohealyx® Study Demonstrating Accelerated Time to Skin Grafting

Mean time to graft reduced to 13.6 days vs. 33.2 days real-world benchmark (~20 day reduction)Median time to...

AVITA Medical Secures 10-Year BARDA Agreement Worth Up to $25.5M to Bolster U.S. Burn Emergency Preparedness

Agreement ensures rapid nationwide access to RECELL® for burn mass casualty incidents, providing BARDA access...

AVITA Medical Showcases Acute Burn and Wound Care Portfolio at ABA 2026, Featuring New Cohealyx Data

Cohealyx® multi-center study interim analysis and new case data to be presentedRECELL® and PermeaDerm® data...

Form S-3 - Registration statement under Securities Act of 1933

AVITA Medical to participate at the TD Cowen 46th Annual Health Care Conference

VALENCIA, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (ASX: AVH, NASDAQ: RCEL), a leading...

AVITA Medical to Host Investor Webinar Briefing

VALENCIA, Calif., Feb. 13, 2026 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (ASX: AVH, NASDAQ: RCEL), a leading...

AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results

VALENCIA, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) -- AVITA Medical®, Inc. (NASDAQ: RCEL, ASX: AVH), a leading...